Invention Grant
- Patent Title: Humanized anti-CDCP1 antibodies
-
Application No.: US13721553Application Date: 2012-12-20
-
Publication No.: US09346886B2Publication Date: 2016-05-24
- Inventor: Johannes Auer , Birgit Bossenmaier , Guy Georges , Alexander Lifke , Ekkehard Moessner , Gerhard Niederfellner
- Applicant: Roche Glycart AG
- Applicant Address: CH Schlieren
- Assignee: Roche Glycart AG
- Current Assignee: Roche Glycart AG
- Current Assignee Address: CH Schlieren
- Priority: EP09011046 20090828; EP10000972 20100201
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/30 ; C07K16/28
Abstract:
The present invention relates to humanized antibodies against human CDCP1 (anti-CDCP1 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Public/Granted literature
- US20130209455A1 Humanized Anti-CDCP1 Antibodies Public/Granted day:2013-08-15
Information query
